The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers
Tài liệu tham khảo
Addington, 1998, Facial affect recognition and information processing in schizophrenia and bipolar disorder, Schizophr Res, 32, 171, 10.1016/S0920-9964(98)00042-5
Amann, 2007, Antiepileptic drugs and mood stability, Clin EEG Neurosci, 38, 116, 10.1177/155005940703800214
Arban, 2005, Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania, Behav Brain Res, 158, 123, 10.1016/j.bbr.2004.08.015
Becker, 2003, Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, 27, 687, 10.1016/S0278-5846(03)00080-0
Berlin, 2007, Antiepileptic drugs for the treatment of post-traumatic stress disorder, Curr Psychiatry Rep, 9, 291, 10.1007/s11920-007-0035-5
Bowden, 2002, Lamotrigine in the treatment of bipolar disorder, Expert Opin Pharmacother, 3, 1513, 10.1517/14656566.3.10.1513
Brignell, 2006, Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning, Psychopharmacology (Berl), 186, 504, 10.1007/s00213-006-0363-x
Burghardt, 2004, The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine, Biol Psychiatry, 55, 1171, 10.1016/j.biopsych.2004.02.029
Calabrese, 2008, Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials, Bipolar Disord, 10, 323, 10.1111/j.1399-5618.2007.00500.x
Calzavara, 2004, Role of anxiety levels in memory performance of spontaneously hypertensive rats, Behav Pharmacol, 15, 545, 10.1097/00008877-200412000-00003
Calzavara, 2009, Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?, Schizophr Bull, 35, 748, 10.1093/schbul/sbn006
Calzavara, 2011, Effects of antipsychotics and amphetamine on social behaviors of the Spontaneously Hypertensive Rat, Behav Brain Res, 225, 15, 10.1016/j.bbr.2011.06.026
Chen, 2007, The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia, Curr Med Res Opin, 23, 1351, 10.1185/030079907X187883
Corrêa, 2007, Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania, Prog Neuropsychopharmacol Biol Psychiatry, 31, 887, 10.1016/j.pnpbp.2007.02.005
Daban, 2006, Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results, J Clin Psychopharmacol, 26, 178, 10.1097/01.jcp.0000204332.64390.f3
Eren, 2007, Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain, Neurochem Res, 32, 1188, 10.1007/s11064-007-9289-x
Fanselow, 1988, Conditional analgesia, defensive freezing, and benzodiazepines, Behav Neurosci, 102, 233, 10.1037/0735-7044.102.2.233
Foreman, 2009, Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test, Eur J Pharmacol, 14;602, 316, 10.1016/j.ejphar.2008.11.013
Fountoulakis, 2008, Treatment of bipolar disorder: a systematic review of available data and clinical perspectives, Int J Neuropsychopharmacol, 11, 999, 10.1017/S1461145708009231
Frey, 2006, Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania, J Psychiatry Neurosci, 31, 326
Gao, 2005, Typical and atypical antipsychotics in bipolar depression, J Clin Psychiatry, 66, 1376, 10.4088/JCP.v66n1106
Gilron, 2006, Neuropathic pain: a practical guide for the clinician, CMAJ, 175, 265, 10.1503/cmaj.060146
Haldane, 2008, Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with lamotrigine monotherapy, Eur Neuropsychopharmacol, 18, 48, 10.1016/j.euroneuro.2007.05.009
Hard, 1985, Behavioral reactivity in spontaneously hypertensive rats, Physiol Behav, 35, 487, 10.1016/0031-9384(85)90128-3
Hernandez, 2003, Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression, J Psychiatry Neurosci, 28, 197
Herz, 1980, Relapse in schizophrenia, Am J Psychiatry, 137, 801, 10.1176/ajp.137.7.801
Inoue, 1996, Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing, Eur J Pharmacol, 311, 1, 10.1016/0014-2999(96)00391-3
Inoue, 2004, Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala, Eur J Pharmacol, 497, 311, 10.1016/j.ejphar.2004.06.061
Janowsky, 1979, Amphetamine psychosis and psychotic symptoms, Psychopharmacology, 65, 73, 10.1007/BF00491982
Knardahl, 1981, Regarding hyperactivity of the SHR in the open-field test, Behav Neural Biol, 32, 274, 10.1016/S0163-1047(81)90663-4
Kohler, 2006, Emotional processing in schizophrenia, Cogn Neuropsychiatry, 11, 250, 10.1080/13546800500188575
Lamberty, 2001, Effect of the new antiepileptic drug levetiracetam in an animal model of mania, Epilepsy Behav, 2, 454, 10.1006/ebeh.2001.0254
LeDoux, 2000, Emotion circuits in the brain, Annu Rev Neurosci, 23, 155, 10.1146/annurev.neuro.23.1.155
Malhi, 2009, Is lithium in a class of its own? A brief profile of its clinical use, Aust N Z J Psychiatry, 43, 1096, 10.3109/00048670903279937
Marsh, 2006, ADHD and schizophrenia phenomenology: visual scanpaths to emotional faces as a potential psychophysiological marker?, Neurosci Biobehav Rev, 30, 651, 10.1016/j.neubiorev.2005.11.004
Meador, 2005, Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers, Neurology, 64, 2108, 10.1212/01.WNL.0000165994.46777.BE
Meneses, 2011, Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats, Behav Brain Res, 216, 472, 10.1016/j.bbr.2010.08.035
Mula, 2007, The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence, J Clin Psychopharmacol, 27, 263, 10.1097/jcp.0b013e318059361a
Munro, 2007, Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety, Neuropharmacology, 53, 609, 10.1016/j.neuropharm.2007.07.002
Muraki, 1999, Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat, Eur J Pharmacol, 383, 223, 10.1016/S0014-2999(99)00572-5
Pezze, 2004, Mesolimbic dopaminergic pathways in fear conditioning, Prog Neurobiol, 74, 301, 10.1016/j.pneurobio.2004.09.004
Phillips, 2003, Neurobiology of emotion perception II: implications for major psychiatric disorders, Biol Psychiatry, 54, 515, 10.1016/S0006-3223(03)00171-9
Resstel, 2006, Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats, Behav Brain Res, 25, 294, 10.1016/j.bbr.2006.05.016
Santos, 2006, Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning, Eur J Pharmacol, 542, 121, 10.1016/j.ejphar.2006.06.019
Shannon, 2007, Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats, Epilepsy Behav, 10, 16, 10.1016/j.yebeh.2006.11.004
Tiihonen, 2009, The efficacy of lamotrigine in clozapine-resistant chizophrenia: a systematic review and meta-analysis, Schizophr Res, 109, 10, 10.1016/j.schres.2009.01.002
Tsaltas, 2007, Enhancing effects of lithium on memory are not by-products of learning or attentional deficits, Behav Brain Res, 180, 241, 10.1016/j.bbr.2007.03.017
Van den Buuse, 1989, Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats, J Pharmacol Exp Ther, 248, 1189
Van Lieshout, 2010, Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review, Br J Psychiatry, 196, 266, 10.1192/bjp.bp.108.057612